Studies found the treatment lowered the risk of hospitalization and eased some symptoms, KDKA's Chris Hoffman reports.
Studies found the treatment lowered the risk of hospitalization and eased some symptoms, KDKA's Chris Hoffman reports.
The treatment is a one hour infusion that's done outpatient and you have to be monitored for an hour afterwards.
There is another hopeful milestone Sunday after the FDA issued an emergency-use authorization for Regeneron's antibody cocktail to..